Central administration of palmitoylethanolamide reduces hyperalgesia in mice via inhibition of NF-kappaB nuclear signalling in dorsal root ganglia.

Source:http://linkedlifedata.com/resource/pubmed/id/19386271

Eur. J. Pharmacol. 2009 Jun 24 613 1-3 54-9

Download in:

View as

General Info

PMID
19386271